fda approval status of ghk-cu adds non-injectable back to Category 1. FDA Thursday re-added non-injectable GHK-Cu to Category 1 the 503A bulks process after the nomination was withdrawn from further review. Injectable GHK-Cu remains Epithalon | True Peptides simpro Variant:DSIP-10PACK
fda approval status of ghk-cuPay in 4 interest-free payments of $5.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27